SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-21-003357
Filing Date
2021-02-04
Accepted
2021-02-04 11:16:01
Documents
15
Period of Report
2021-02-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc10019731_8k.htm   iXBRL 8-K 37865
2 EXHIBIT 99.1 brhc10019731_ex99-1.htm EX-99.1 27048
7 image00001.jpg GRAPHIC 4708
  Complete submission text file 0001140361-21-003357.txt   281566

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mrk-20210201.xsd EX-101.SCH 5411
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mrk-20210201_def.xml EX-101.DEF 19399
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE mrk-20210201_lab.xml EX-101.LAB 30020
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mrk-20210201_pre.xml EX-101.PRE 21813
8 EXTRACTED XBRL INSTANCE DOCUMENT brhc10019731_8k_htm.xml XML 10481
Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Filer) CIK: 0000310158 (see all company filings)

IRS No.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-06571 | Film No.: 21589646
SIC: 2834 Pharmaceutical Preparations